Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Nuzzo, Russo, Errico, D’Amico et al. investigate neuroinflammation in forty-eight pediatric spinal muscular atrophy patients before and after Nusinersen treatment. They find signatures of neuroinflammation that are specifically associated with severe disease and show that Nusinersen therapy has neur...
Main Authors: | Tommaso Nuzzo, Rosita Russo, Francesco Errico, Adele D’Amico, Awet G. Tewelde, Mariangela Valletta, Amber Hassan, Michele Tosi, Chiara Panicucci, Claudio Bruno, Enrico Bertini, Angela Chambery, Livio Pellizzoni, Alessandro Usiello |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-023-00256-2 |
Similar Items
-
Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy
by: Francesco Errico, et al.
Published: (2022-10-01) -
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
by: Valeria Valsecchi, et al.
Published: (2023-11-01) -
Spinal muscular atrophy
by: D'Amico Adele, et al.
Published: (2011-11-01) -
Nusinersen and spinal muscular atrophies: Where are we in 2020?
by: Satish V Khadilkar, et al.
Published: (2020-01-01) -
Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen
by: Aragon-Gawinska, K, et al.
Published: (2019)